======= ASH1L ======= == Gene Information == * **Official Symbol**: ASH1L * **Official Name**: ASH1 like histone lysine methyltransferase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55870|55870]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NR48|Q9NR48]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ASH1L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ASH1L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607999|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone methyltransferase specifically methylating 'Lys- 36' of histone H3 (H3K36me). {ECO:0000269|PubMed:21239497}. |Bromodomain| |PHD| |BAH| |SET| |uterine gland development| |tarsal gland development| |histone H3-K36 dimethylation| |uterus morphogenesis| |histone methyltransferase activity (H3-K36 specific)| |sebaceous gland development| |histone H3-K36 methylation| |histone methyltransferase activity (H3-K9 specific)| |interleukin-6 production| |negative regulation of acute inflammatory response| |peptidyl-lysine dimethylation| |histone H3-K9 methylation| |histone methyltransferase activity (H3-K4 specific)| |histone H3-K9 modification| |uterus development| |decidualization| |maternal placenta development| |histone H3-K4 methylation| |negative regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of acute inflammatory response| |maternal process involved in female pregnancy| |sperm motility| |flagellated sperm motility| |histone lysine methylation| |peptidyl-lysine methylation| |post-embryonic development| |histone methylation| |cilium or flagellum-dependent cell motility| |cilium-dependent cell motility| |chromosome| |bicellular tight junction| |protein methylation| |protein alkylation| |negative regulation of inflammatory response| |single fertilization| |cytokine production| |placenta development| |negative regulation of MAPK cascade| |fertilization| |DNA packaging| |female pregnancy| |negative regulation of defense response| |multi-multicellular organism process| |regulation of I-kappaB kinase/NF-kappaB signaling| |macromolecule methylation| |DNA conformation change| |methylation| |peptidyl-lysine modification| |regulation of inflammatory response| |negative regulation of response to external stimulus| |histone modification| |covalent chromatin modification| |skin development| |chromatin binding| |negative regulation of protein phosphorylation| |gland development| |reproductive structure development| |reproductive system development| |negative regulation of phosphorylation| |transcription by RNA polymerase II| |skeletal system development| |negative regulation of intracellular signal transduction| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |developmental process involved in reproduction| |chromatin organization| |regulation of MAPK cascade| |regulation of defense response| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |peptidyl-amino acid modification| |animal organ morphogenesis| |Golgi apparatus| |multi-organism reproductive process| |negative regulation of cellular protein metabolic process| |chromosome organization| |cell motility| |localization of cell| |regulation of response to external stimulus| |nucleobase-containing compound biosynthetic process| |negative regulation of protein metabolic process| |cell-cell signaling| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |negative regulation of signal transduction| |organic cyclic compound biosynthetic process| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |reproductive process| |reproduction| |regulation of protein phosphorylation| |DNA binding| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of phosphorylation| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.24| |[[:results:exp534|Trientine 500μM R08 exp534]]|-1.76| |[[:results:exp148|SB202190 10μM R03 exp148]]|1.93| |[[:results:exp149|SB203580 25μM R03 exp149]]|2.18| |[[:results:exp144|PFI-3 10μM R03 exp144]]|2.35| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 6/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10847 * **Expression level (log2 read counts)**: 6.95 {{:chemogenomics:nalm6 dist.png?nolink |}}